Biopharma Advances Demand Specialized Expertise

Publication
Article
BioPharm InternationalBioPharm International-06-15-2015
Volume 2015 eBook
Issue 1

Contract service providers share insights on biopharma market developments and the implications of biosimilar drug approvals.

 

The approval of the first biosimilar in the United States, as well as continuing consolidation in the biopharma and contract development and manufacturing markets, are just two indicators of the ongoing evolution of biopharmaceutical development. Representatives of contract service providers shared observations, trends and projections with BioPharm International.

 

Download

BioPharm International’s 2015 Outsourcing Resources eBook

.

 

 

 

 

 

 

Articles in this issue
BPsupp0615__QRM_200.jpg
QRM Tools for Contract Biomanufacturing
BPsupp0615_LangerFillFinish_200.jpg
Fill/Finish Trends
BPsupp0615_Feature_roundtable_200.jpg
Biopharma Advances Demand Specialized Expertise
BPsupp0615_IPLaw_200.jpg
Protecting Intellectual Property in Engagements with CMOs
BPsupp0615_Neostem_200.jpg
Taking a “Development-by-Design” Approach to Cell Therapies
Recent Videos
David Fairen-Jimenez
Industry Outlook 2025: The Rising Prominence of AI in Pharma
William K. Oh, MD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Eswar Iyer, Aikium Inc.
Leroy (Lee) Hood, MD, PhD
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Google Launches AI System to Aid Scientific Research

Susan Haigney
February 20th 2025
Article

The new AI co-scientist is a multi-agent AI system that acts as a virtual scientific collaborator to aid scientific research.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Voyager Pauses IND Filing while Assessing Alternate Payloads for SOD1 ALS Gene Therapy Program

Feliza Mirasol
February 13th 2025
Article

The company plans to assess alternate payloads for its gene therapy program, which will shift its timeline.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Black female scientist looking through microscope while working in laboratory. | Image Credit: ©Drazen - stock.adobe.com

The 10th Anniversary of the International Day of Women and Girls in Science

Susan Haigney
February 11th 2025
Article

Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.

Medical capsule with DNA inside, 3d rendering. | © Vink Fan– Stock.Adobe.com – © Vink Fan – stock.adobe.com

Navigating a Growing Field of New Biotherapeutic Modalities

Feliza Mirasol
February 7th 2025
Article

Development of new modalities of biotherapeutic molecules will rely on manufacturing, regulatory, and collaborative support.

© 2025 MJH Life Sciences

All rights reserved.